SBIR Phase I: Portable Blood Diagnostic Technology Enabling Care Delivery Beyond Hospital — NSF Award to Kompass Diagnostics Inc (
The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project will be the advancement of a portable, cost-effective rapid point of care diagnostic device that utilizes high sensitivity biosensors for detecting multiple blood-based biomarkers. Starting with reproductive hormon
| Award title | SBIR Phase I: Portable Blood Diagnostic Technology Enabling Care Delivery Beyond Hospital |
|---|---|
| Award ID | 2507280 |
| Awardee | Kompass Diagnostics Inc |
| City | CHICAGO |
| State | IL |
| Amount obligated | $304,966 |
| Principal investigator | Hyun-June Jang |
| Program | SBIR Phase I |
| Start date | 05/01/2025 |
| Abstract | The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project will be the advancement of a portable, cost-effective rapid point of care diagnostic device that utilizes high sensitivity biosensors for detecting multiple blood-based biomarkers. Starting with reproductive hormones, this technology empowers clinicians to obtain rapid hormone level results to support time-sensitive clinical decisions in fertility treatments such as in-vitro fertilization an |
| Source | NSF Awards |
$799/mo
Try NSFGrants →